冷泉港亞洲2013會議：疫苗設(shè)計(jì)
Vaccine Design
疫苗設(shè)計(jì)
2013年6月3-7日 | 蘇州獨(dú)墅湖會議酒店
|
科學(xué)組委會成員: Michael Good, Griffith University, AUSTRALIA Yiming Shao, Chinese Center for Disease Control and Prevention, CHINA Linqi Zhang, Tsinghua University, CHINA |
主題演講嘉賓:
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
特邀演講嘉賓:
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
會議主題：
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
|
|
聯(lián)系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: [email protected] Website: www.csh-asia.org |
相關(guān)鏈接： 2013年冷泉港亞洲（CSH Asia）會議搶先預(yù)覽！
- 2025第四屆中部（長沙）科學(xué)儀器及實(shí)驗(yàn)室裝備展通知
- 第十屆BPI WEEK 2025 生物醫(yī)藥創(chuàng)新周議程首發(fā)
- 2025成都細(xì)胞生物產(chǎn)業(yè)大會通知
- 共襄盛會導(dǎo)向行業(yè)新程，中檢葆泰亮相糧油質(zhì)檢年會
- BIOCHINA 2025第十屆易貿(mào)生物產(chǎn)業(yè)大會通知
- 易科泰邀您參加第四屆三亞國際種業(yè)科學(xué)家大會
- 2025第25屆合肥食品安全檢測技術(shù)高峰論壇通知
- 進(jìn)科馳安攜流式分選儀等參加全國細(xì)胞外囊泡大會
- 第7屆北京國際醫(yī)療器械及醫(yī)院建設(shè)展火熱招商中
- CPHI&PMEC 2025世界制藥原料中國展預(yù)登記已開啟
- 第十七屆ChinaBio®生物醫(yī)藥產(chǎn)業(yè)國際合作大會通知
- 2025北京檢驗(yàn)醫(yī)療與體外診斷及耗材展火熱招商中
- 霍爾斯參加2024未來微藻生物制造創(chuàng)新研討會
- 2024年I2SL國際可持續(xù)發(fā)展實(shí)驗(yàn)室會議成功舉辦
- 澤權(quán)儀器精彩亮相2024科學(xué)家創(chuàng)新大會
- 2024第九屆疫苗中國領(lǐng)導(dǎo)者年會通知
- MCE推出超900種一抗和多種二抗產(chǎn)品，涵蓋熱門靶點(diǎn)
- 丹納赫將收購Abcam以推動生命科學(xué)領(lǐng)域研究創(chuàng)新進(jìn)程
- 睿捷生物新學(xué)期新福利，四重優(yōu)惠限時(shí)享
- 佰諾全景科研mIHC病理技術(shù)服務(wù)年中大促銷火熱來襲
- 西美杰KPL熱銷二抗和底物限時(shí)優(yōu)惠活動已啟動！
- 美國Jackson二抗產(chǎn)品暑期促銷
- PhytoAB推出調(diào)節(jié)ABA受體PYLs相關(guān)蛋白抗體
- 菲恩生物推出抗體等試劑產(chǎn)品五一節(jié)三重禮促銷活動
- 2023疫苗創(chuàng)新國際論壇通知
- 西美杰Dylight標(biāo)記抗體促銷活動開始啦！
- 百賽生物與美國時(shí)令生物達(dá)成戰(zhàn)略合作！
- VacCon 2022第四屆新型疫苗研發(fā)與產(chǎn)業(yè)化論壇通知
- 第三屆中國(廣州)抗體藥物開發(fā)與工藝創(chuàng)新大會通知
- 雙11大促 - Abcam抗體叕鉅惠買二贈一，多買多送
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：[email protected]